Inlägg av Iptor

Business Consultant – Publishing (United States)

General: As a Business Consultant, you contribute to the profitability of the Professional Services (PS) business line, specifically providing and delivering first-class services and support across Iptor’s product portfolio, by understanding customer business requirements to ensure added-value solution. Responsibilities of this role include, but are not necessarily limited to, the duties listed on this job […]

Why haven’t pharmaceutical distributors embraced the cloud?

It seems almost counterintuitive to write a blog post, at this moment in 2021, advocating for the use of cloud solutions as the foundation of a business’ computing infrastructure. It’s been 14 years since Google CEO Eric Schmidt introduced the phrase into the common vernacular, and the idea behind cloud computing has been around much […]

Switching from Pandemic to Growth Mindset

This time last year, following recent investment into Iptor, I was quietly confident that I would soon be able to share exciting pieces of news like the one we’ve announced today (our Mesa acquisition). I had just arrived at Philadelphia airport to visit some of our US key accounts and to start laying the groundwork […]

Business Consultant (United States / Remote)

General: As a Business Consultant, you will contribute to the profitability of the Professional Services (PS) business line, specifically by providing and delivering first-class services and support across Iptor’s product portfolio, and by understanding customer business requirements to ensure an added-value solution. Responsibilities may include, but are not necessarily limited to, the duties listed on […]

3 Reasons Pharma Distributors Should be Wary of Pandemic-Related DSCSA Exemptions

The Drug Supply Chain Security Act (DSCSA) obligates US pharmaceutical manufacturers, wholesale distributors, dispensers and re-packagers to participate in an interoperable exchange that monitors the distribution of drugs to prevent counterfeit or contaminated drugs. However, for pharmaceutical distributors, the COVID-19 pandemic constitutes a public health emergency that automatically excludes certain activities from DSCSA requirements. COVID-19 […]